Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
RSV
Manufacturing
Moderna takes $238M contract manufacturing cancellation charge
In 2024’s fourth quarter, Moderna weathered a $238 million charge tied to the cancellation of a contract manufacturing agreement.
Fraiser Kansteiner
Feb 14, 2025 11:05am
JPM25: Moderna slashes costs, guidance amid poor vaccine sales
Jan 13, 2025 11:31am
FDA requires Pfizer, GSK to add new warning label on RSV shots
Jan 8, 2025 11:57am
Moderna CEO confronts challenges for RSV, COVID businesses
Jan 7, 2025 11:00am
More testing needed after Moderna trial halted by FDA: experts
Dec 13, 2024 8:15am
Moderna disappoints in RSV debut, excels in COVID sales
Nov 7, 2024 10:51am